TY  - GEN
AU  - Lodi, Sara
AU  - Phillips, Andrew
AU  - Fidler, Sarah
AU  - Hawkins, David
AU  - Gilson, Richard
AU  - McLean, Ken
AU  - Fisher, Martin
AU  - Post, Frank
AU  - Johnson, Anne M
AU  - Walker-Nthenda, Louise
AU  - Dunn, David
AU  - Porter, Kholoud
PY  - 2013
DO  - 10.1371/journal.pone.0075608
SN  - 1932-6203
UR  - http://hdl.handle.net/20.500.12105/8730
AB  - BACKGROUND: The development of HIV drug resistance and subsequent virological failure are often cited as potential disadvantages of early cART initiation. However, their long-term probability is not known, and neither is the role of duration of...
LA  - eng
PB  - Public Library of Science (PLOS)
KW  - Anti-HIV Agents
KW  - Anti-Retroviral Agents
KW  - CD4 Lymphocyte Count
KW  - CD4-Positive T-Lymphocytes
KW  - Drug Resistance, Viral
KW  - Drug Therapy, Combination
KW  - Female
KW  - HIV
KW  - HIV Infections
KW  - HIV Seropositivity
KW  - Humans
KW  - Male
KW  - Risk
KW  - Treatment Failure
TI  - Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failure
TY  - research article
ER  -